sGC-1061

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamesGC-1061

Drug Alias NameNitric oxide mimeticSustained-release sGC-1061Nomethiazoles (NO-chimera prodrugs)sGC-1061

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau inhibitors

TargetsMicrotubule-associated protein tauBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSgc Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSgc Pharma

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A